| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VACCINEX, INC. | Director | Stock Option (Right to Buy) | 28.6K | $22K | $0.77 | May 11, 2021 | Direct |
| VACCINEX, INC. | Director | Common Stock | 300 | $216 | $0.72 | May 11, 2021 | Direct |
| LogicBio Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct | ||
| Surface Oncology, Inc. | Director | Common Stock | 0 | $0.94 | Sep 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SURF | Surface Oncology, Inc. | Sep 8, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
| LOGC | LogicBio Therapeutics, Inc. | Nov 16, 2022 | 1 | $0 | 4 | Nov 17, 2022 | Director |
| LOGC | LogicBio Therapeutics, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| SURF | Surface Oncology, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| SURF | Surface Oncology, Inc. | Jul 21, 2021 | 1 | -$779K | 4 | Jan 14, 2022 | Director |
| LOGC | LogicBio Therapeutics, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
| SURF | Surface Oncology, Inc. | Jun 10, 2021 | 8 | -$901K | 4 | Jun 11, 2021 | Director |
| VCNX | VACCINEX, INC. | May 11, 2021 | 1 | $0 | 4 | May 12, 2021 | Director |